Dr Richard Kevin

Conjoint Senior Lecturer

PhD (Science), B. Psych (Hons I)

Medicine & Health

School of Clinical Medicine

Dr Richard Kevin is a Senior Hospital Scientist at St Vincent's Hospital Sydney, and a Conjoint Senior Lecturer in the School of Clinical Medicine UNSW.

Richard completed his doctoral studies at The University of Sydney in psychopharmacology and analytical chemistry, with a particular focus on cannabinoids and related compounds. He has strong research interests in pharmacokinetics, drug-drug interactions, and therapeutic drug monitoring. He now leads an analytical laboratory (primarily HPLC and mass spectrometry) in St Vincent's Centre for Applied Medical Research (AMR), which develops new analytical methodologies for quantification of a variety of drugs and medications.

��

E-mail

r.kevin@unsw.edu.au

Location

St Vincent's Centre for Applied Medical Research Lowy Packer Building, 405 Liverpool Street, Darlinghurst NSW 2010, Australia

Journal articles | 2024

Bawa Z; Lewis D; Gavin PD; Libinaki R; Joubran L; El-Tamimy M; Taylor G; Meltzer R; Bedoya-Pérez M; Kevin RC; McGregor IS, 2024, 'An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis', Scientific Reports, 14,

Journal articles | 2024

Maguire S; Kesby A; Brownlow R; Hunt GE; Kim M; McAulay C; Grisham JR; McGregor IS; Suraev A; Kevin RC; Russell J, 2024, 'A phase II randomised controlled trial of intranasal oxytocin in anorexia nervosa', Psychoneuroendocrinology, 164,

Journal articles | 2024

Sparkes E; Maloney CJ; Markham JW; Dane C; Boyd R; Gilchrist J; Moir M; Gordon R; Luo JL; Pike E; Walker KA; Kassiou M; McGregor IS; Kevin RC; Hibbs DE; Jorgensen WT; Banister SD; Cairns EA; Ametovski A, 2024, 'Structure-Activity Relationships, Deuteration, and Fluorination of Synthetic Cannabinoid Receptor Agonists Related to AKB48, 5F-AKB-48, and AFUBIATA', ACS Chemical Neuroscience, 15, pp. 2160 - 2181,

Journal articles | 2024

Sparkes E; Markham JW; Boyd R; Udoh M; Gordon R; Zaman H; Walker KA; Dane C; Kevin RC; Santiago MJ; Hibbs DE; Banister SD; Ametovski A; Cairns EA, 2024, 'Synthesis and functional evaluation of proteinogenic amino acid-derived synthetic cannabinoid receptor agonists related to MPP-5F-PICA, MMB-5F-PICA, and MDMB-5F-PICA', RSC Medicinal Chemistry, 15, pp. 2063 - 2079,

Journal articles | 2024

Sparkes E; Timmerman A; Markham JW; Boyd R; Gordon R; Walker KA; Kevin RC; Hibbs DE; Banister SD; Cairns EA; Stove C; Ametovski A, 2024, 'Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA', ACS Chemical Neuroscience, 15, pp. 1787 - 1812,

Journal articles | 2024

Suraev A; McCartney D; Kevin R; Gordon R; Grunstein RR; Hoyos CM; McGregor IS, 2024, 'Detection of Δ⁹-tetrahydrocannabinol (THC) in oral fluid using two point-of-collection testing devices following oral administration of a THC and cannabidiol��containing oil', Drug Testing and Analysis,

Journal articles | 2023

Bahceci D; Anderson LL; Kevin RC; Doohan PT; Arnold JC, 2023, 'Hyperthermia-Induced Seizures Enhance Brain Concentrations of the Endocannabinoid-Related Linoleoyl Glycerols in a Scn1a^+/-Mouse Model of Dravet Syndrome', Cannabis and Cannabinoid Research, 8, pp. 495 - 504,

Journal articles | 2023

Harman T; Udoh M; McElroy DL; Anderson LL; Kevin RC; Banister SD; Ametovski A; Markham J; Bladen C; Doohan PT; Greba Q; Laprairie RB; Snutch TP; McGregor IS; Howland JG; Arnold JC, 2023, 'MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy', Frontiers in Physiology, 14,

Journal articles | 2023

McCartney D; Kevin RC; Suraev AS; Sahinovic A; Doohan PT; Bedoya-Pérez MA; Grunstein RR; Hoyos CM; McGregor IS, 2023, 'How long does a single oral dose of cannabidiol persist in plasma? Findings from three clinical trials', Drug Testing and Analysis, 15, pp. 334 - 344,

Journal articles | 2023

Mosley PE; Webb L; Suraev A; Hingston L; Turnbull T; Foster K; Ballard E; Gomes L; Mohan A; Sachdev PS; Kevin R; Gordon R; Benson M; McGregor IS, 2023, 'Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome.', NEJM Evid, 2, pp. EVIDoa2300012,

Journal articles | 2022

Arkell TR; Kevin RC; Vinckenbosch F; Lintzeris N; Theunissen E; Ramaekers JG; McGregor IS, 2022, 'Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials', Addiction Biology, 27,

Journal articles | 2022

Benson MJ; Anderson LL; Low IK; Luo JL; Kevin RC; Zhou C; Mcgregor IS; Arnold JC, 2022, 'Evaluation of the Possible Anticonvulsant Effect of Δ⁹-Tetrahydrocannabinolic Acid in Murine Seizure Models', Cannabis and Cannabinoid Research, 7, pp. 46 - 57,

Journal articles | 2022

Berger M; Li E; Rice S; Davey CG; Ratheesh A; Adams S; Jackson H; Hetrick S; Parker A; Spelman T; Kevin R; McGregor IS; McGorry P; Amminger GP, 2022, 'Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label Trial', Journal of Clinical Psychiatry, 83,

Journal articles | 2022

Hutten NRPW; Arkell TR; Vinckenbosch F; Schepers J; Kevin RC; Theunissen EL; Kuypers KPC; McGregor IS; Ramaekers JG, 2022, 'Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis', Psychopharmacology, 239, pp. 3731 - 3741,

Journal articles | 2022

Kevin RC; Cairns EA; Boyd R; Arnold JC; Bowen MT; McGregor IS; Banister SD, 2022, 'Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11', Frontiers in Psychiatry, 13,

Journal articles | 2022

Kevin RC; Mirlohi S; Manning JJ; Boyd R; Cairns EA; Ametovski A; Lai F; Luo JL; Jorgensen W; Ellison R; Gerona RR; Hibbs DE; McGregor IS; Glass M; Connor M; Bladen C; Zamponi GW; Banister SD, 2022, 'Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T-Type Calcium Channel (CaV3) Inhibitors', ACS Chemical Neuroscience, 13, pp. 1395 - 1409,

Journal articles | 2022

Markham J; Sparkes E; Boyd R; Chen S; Manning JJ; Finlay D; Lai F; McGregor E; Maloney CJ; Gerona RR; Connor M; McGregor IS; Hibbs DE; Glass M; Kevin RC; Banister SD, 2022, 'Defining Steric Requirements at CB1and CB2Cannabinoid Receptors Using Synthetic Cannabinoid Receptor Agonists 5F-AB-PINACA, 5F-ADB-PINACA, PX-1, PX-2, NNL-1, and Their Analogues', ACS Chemical Neuroscience, 13, pp. 1281 - 1295,

Journal articles | 2022

McCartney D; Arkell TR; Irwin C; Kevin RC; McGregor IS, 2022, 'Are blood and oral fluid Δ⁹-tetrahydrocannabinol (THC) and metabolite concentrations related to impairment? A meta-regression analysis', Neuroscience and Biobehavioral Reviews, 134,

Journal articles | 2022

McCartney D; Kevin RC; Suraev AS; Irwin C; Grunstein RR; Hoyos CM; McGregor IS, 2022, 'Orally administered cannabidiol does not produce false-positive tests for Δ⁹-tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000', Drug Testing and Analysis, 14, pp. 137 - 143,

Journal articles | 2022

McCartney D; Suraev AS; Doohan PT; Irwin C; Kevin RC; Grunstein RR; Hoyos CM; McGregor IS, 2022, 'Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial', Journal of Psychopharmacology, 36, pp. 1338 - 1349,

Journal articles | 2022

Sahinovic A; Irwin C; Doohan PT; Kevin RC; Cox AJ; Lau NS; Desbrow B; Johnson NA; Sabag A; Hislop M; Haber PS; McGregor IS; McCartney D, 2022, 'Effects of Cannabidiol on Exercise Physiology and Bioenergetics: A Randomised Controlled Pilot Trial', Sports Medicine - Open, 8,

Journal articles | 2022

Sparkes E; Cairns EA; Kevin RC; Lai F; Grafinger KE; Chen S; Deventer MH; Ellison R; Boyd R; Martin LJ; McGregor IS; Gerona RR; Hibbs DE; Auwärter V; Glass M; Stove C; Banister SD, 2022, 'Structure-activity relationships of valine, tert -leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA', RSC Medicinal Chemistry, 13, pp. 156 - 174,

Journal articles | 2021

Ametovski A; Cairns EA; Grafinger KE; Cannaert A; Deventer MH; Chen S; Wu X; Shepperson CE; Lai F; Ellison R; Gerona R; Blakey K; Kevin R; McGregor IS; Hibbs DE; Glass M; Stove C; Auwärter V; Banister SD, 2021, 'NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity?', ACS Chemical Neuroscience, 12, pp. 4020 - 4036,

Journal articles | 2021

Anderson LL; Doohan PT; Oldfield L; Kevin RC; Arnold JC; Berger M; Amminger GP; Mcgregor IS, 2021, 'Citalopram and Cannabidiol: In Vitro and In Vivo Evidence of Pharmacokinetic Interactions Relevant to the Treatment of Anxiety Disorders in Young People', Journal of Clinical Psychopharmacology, 41, pp. 525 - 533,

Journal articles | 2021

Arkell TR; Spindle TR; Kevin RC; Vandrey R; McGregor IS, 2021, 'The failings of per se limits to detect cannabis-induced driving impairment: Results from a simulated driving study', Traffic Injury Prevention, 22, pp. 102 - 107,

Journal articles | 2021

Kevin RC; Vogel R; Doohan P; Berger M; Amminger GP; McGregor IS, 2021, 'A validated method for the simultaneous quantification of cannabidiol, Δ⁹-tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open-label trial', Drug Testing and Analysis, 13, pp. 614 - 627,

Journal articles | 2021

Sahinovic A; Irwin C; Kevin RC; Cox AJ; Lau NS; Desbrow B; Johnson NA; Sabag A; Hislop M; Haber PS; McGregor IS; McCartney D, 2021, 'The Effect Of Cannabidiol (CBD) On Exercise Physiology And Bioenergetics: A Randomised Controlled Pilot Trial', Medicine & Science in Sports & Exercise, 53, pp. 280 - 280,

Journal articles | 2020

Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG, 2020, 'Effect of Cannabidiol and ?⁹-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial', JAMA - Journal of the American Medical Association, 324, pp. 2177 - 2186,

Journal articles | 2020

Assareh N; Gururajan A; Zhou C; Luo JL; Kevin RC; Arnold JC, 2020, 'Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice', Behavioural Pharmacology, 31, pp. 591 - 596,

Journal articles | 2020

Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP, 2020, 'Synthesis and in Vitro Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A-CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICA', ACS Chemical Neuroscience, 11, pp. 4434 - 4446,

Journal articles | 2020

Gamage TF; Barrus DG; Kevin RC; Finlay DB; Lefever TW; Patel PR; Grabenauer MA; Glass M; McGregor IS; Wiley JL; Thomas BF, 2020, 'In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018', Pharmacology Biochemistry and Behavior, 193,

Journal articles | 2020

Lintzeris N; Mills L; Dunlop A; Copeland J; Mcgregor I; Bruno R; Kirby A; Montebello M; Hall M; Jefferies M; Kevin R; Bhardwaj A, 2020, 'Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial', Drug and Alcohol Dependence, 215,

Journal articles | 2019

Arkell TR; Kevin RC; Stuart J; Lintzeris N; Haber PS; Ramaekers JG; McGregor IS, 2019, 'Detection of Δ⁹ THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point-of-collection testing devices', Drug Testing and Analysis, 11, pp. 1486 - 1497,

Journal articles | 2019

Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS, 2019, 'Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition', Psychopharmacology, 236, pp. 2713 - 2724,

Journal articles | 2019

Banister SD; Adams A; Kevin RC; Macdonald C; Glass M; Boyd R; Connor M; McGregor IS; Havel CM; Bright SJ; Vilamala MV; Lladanosa CG; Barratt MJ; Gerona RR, 2019, 'Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA', Drug Testing and Analysis, 11, pp. 279 - 291,

Journal articles | 2019

Banister SD; Kevin RC; Martin L; Adams A; Macdonald C; Manning JJ; Boyd R; Cunningham M; Stevens MY; McGregor IS; Glass M; Connor M; Gerona RR, 2019, 'The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogs', Drug Testing and Analysis, 11, pp. 976 - 989,

Journal articles | 2019

Bedoya-Perez MA; Smith KL; Kevin RC; Luo JL; Crowther MS; Mcgregor IS, 2019, 'Parameters that affect fear responses in rodents and how to use them for management', Frontiers in Ecology and Evolution, 7,

Journal articles | 2019

Gamage TF; Farquhar CE; McKinnie RJ; Kevin RC; McGregor IS; Trudell ML; Wiley JL; Thomas BF, 2019, 'Synthetic cannabinoid hydroxypentyl metabolites retain efficacy at human cannabinoid receptors', Journal of Pharmacology and Experimental Therapeutics, 368, pp. 414,

Journal articles | 2019

Kevin RC; Anderson L; McGregor IS; Boyd R; Manning JJ; Glass M; Connor M; Banister SD, 2019, 'CuMyl-4CN-BINACA is an efficacious and potent pro-convulsant synthetic cannabinoid receptor agonist', Frontiers in Pharmacology, 10,

Journal articles | 2019

Kevin RC; Kovach AL; Lefever TW; Gamage TF; Wiley JL; McGregor IS; Thomas BF, 2019, 'Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures', Forensic Toxicology, 37, pp. 17 - 26,

Journal articles | 2019

Lintzeris N; Bhardwaj A; Mills L; Dunlop A; Copeland J; McGregor I; Bruno R; Gugusheff J; Phung N; Montebello M; Chan T; Kirby A; Hall M; Jefferies M; Luksza J; Shanahan M; Kevin R; Allsop D, 2019, 'Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial', JAMA Internal Medicine, 179, pp. 1242 - 1253,

Journal articles | 2018

Banister SD; Olson A; Winchester M; Stuart J; Edington AR; Kevin RC; Longworth M; Herrera M; Connor M; McGregor IS; Gerona RR; Kassiou M, 2018, 'The chemistry and pharmacology of synthetic cannabinoid SDB-006 and its regioisomeric fluorinated and methoxylated analogs', Drug Testing and Analysis, 10, pp. 1099 - 1109,

Journal articles | 2018

Gamage TF; Farquhar CE; Lefever TW; Marusich JA; Kevin RC; McGregor IS; Wiley JL; Thomas BF, 2018, 'Molecular and behavioral pharmacological characterization of abused synthetic cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA', Journal of Pharmacology and Experimental Therapeutics, 365, pp. 437 - 446,

Journal articles | 2018

Kevin RC; Lefever TW; Snyder RW; Patel PR; Fennell TR; Wiley JL; McGregor IS; Thomas BF, 2018, 'Erratum to: In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA (Forensic Toxicol, (2017), 35, (333–347), 10.1007/s11419-017-0361-1)', Forensic Toxicology, 36, pp. 229,

Journal articles | 2018

Kevin RC; Lefever TW; Snyder RW; Patel PR; Gamage TF; Fennell TR; Wiley JL; McGregor IS; Thomas BF, 2018, 'Kinetic and metabolic profiles of synthetic cannabinoids NNEI and MN-18', Drug Testing and Analysis, 10, pp. 137 - 147,

Journal articles | 2018

Suraev A; Lintzeris N; Stuart J; Kevin RC; Blackburn R; Richards E; Arnold JC; Ireland C; Todd L; Allsop DJ; McGregor IS, 2018, 'Composition and use of cannabis extracts for childhood epilepsy in the australian community', Scientific Reports, 8,

Journal articles | 2018

Suraev A; Lintzeris N; Stuart J; Kevin RC; Blackburn R; Richards E; Arnold JC; Ireland C; Todd L; Allsop DJ; McGregor IS, 2018, 'Erratum to: Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community (Scientific Reports, (2018), 8, 1, (10154), 10.1038/s41598-018-28127-0)', Scientific Reports, 8,

Journal articles | 2017

Kevin RC; Allsop DJ; Lintzeris N; Dunlop AJ; Booth J; McGregor IS, 2017, 'Urinary cannabinoid levels during nabiximols (Sativex^®)-medicated inpatient cannabis withdrawal', Forensic Toxicology, 35, pp. 33 - 44,

Journal articles | 2017

Kevin RC; Lefever TW; Snyder RW; Patel PR; Fennell TR; Wiley JL; McGregor IS; Thomas BF, 2017, 'In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA', Forensic Toxicology, 35, pp. 333 - 347,

Journal articles | 2017

Kevin RC; Wood KE; Stuart J; Mitchell AJ; Moir M; Banister SD; Kassiou M; McGregor IS, 2017, 'Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA', Journal of Psychopharmacology, 31, pp. 757 - 769,

Journal articles | 2017

Lefever TW; Marusich JA; Thomas BF; Barrus DG; Peiper NC; Kevin RC; Wiley JL, 2017, 'Vaping synthetic cannabinoids: A novel preclinical model of E-cigarette use in mice', Substance Abuse: Research and Treatment, 11,

Journal articles | 2017

Longworth M; Banister SD; Boyd R; Kevin RC; Connor M; McGregor IS; Kassiou M, 2017, 'Pharmacology of Cumyl-Carboxamide Synthetic Cannabinoid New Psychoactive Substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and Their Analogues', ACS Chemical Neuroscience, 8, pp. 2159 - 2167,

Journal articles | 2017

Thomas BF; Lefever TW; Cortes RA; Grabenauer M; Kovach AL; Cox AO; Patel PR; Pollard GT; Marusich JA; Kevin RC; Gamage TF; Wiley JL, 2017, 'Thermolytic degradation of synthetic cannabinoids: Chemical exposures and pharmacological consequences', Journal of Pharmacology and Experimental Therapeutics, 361, pp. 162 - 171,

Journal articles | 2016

Banister SD; Longworth M; Kevin R; Sachdev S; Santiago M; Stuart J; Mack JBC; Glass M; McGregor IS; Connor M; Kassiou M, 2016, 'Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues', ACS Chemical Neuroscience, 7, pp. 1241 - 1254,

Journal articles | 2015

Banister SD; Moir M; Stuart J; Kevin RC; Wood KE; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Glass M; Connor M; McGregor IS; Kassiou M, 2015, 'Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA', ACS Chemical Neuroscience, 6, pp. 1546 - 1559,

Journal articles | 2015

Banister SD; Stuart J; Conroy T; Longworth M; Manohar M; Beinat C; Wilkinson SM; Kevin RC; Hibbs DE; Glass M; Connor M; McGregor IS; Kassiou M, 2015, 'Structure–activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues', Forensic Toxicology, 33, pp. 355 - 366,

Journal articles | 2015

Banister SD; Stuart J; Kevin RC; Edington A; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Hibbs DE; Glass M; Connor M; McGregor IS; Kassiou M, 2015, 'Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135', ACS Chemical Neuroscience, 6, pp. 1445 - 1458,

Journal articles | 2013

Bowen MT; Kevin RC; May M; Staples LG; Hunt GE; McGregor IS, 2013, 'Defensive Aggregation (Huddling) in Rattus Norvegicus toward Predator Odor: Individual Differences, Social Buffering Effects and Neural Correlates', PLoS ONE, 8,

Journal articles | 2013

Ramos L; Hicks C; Kevin R; Caminer A; Narlawar R; Kassiou M; McGregor IS, 2013, 'Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: Involvement of the V1 a receptor', Neuropsychopharmacology, 38, pp. 2249 - 2259,
Conference Abstracts | 2019

Lintzeris N; Mills L; Dunlop AJ; Copeland J; McGregor I; Bruno R; Gugusheff J; Nghi P; Montebello M; Chan T; Kirby A; Hall M; Bhardwaj A; Jefferies M; Luksza J; Shanahan M; Kevin R; Allsop D, 2019, 'EFFICACY OF NABIXIMOLS IN REDUCING FREQUENCY OF CANNABIS USE THREE MONTHS AFTER TREATMENT CESSATION: RESULTS FROM A RANDOMISED CONTROLLED TRIAL', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S66 - S67,

Preprints | 2018

Banister SD; Kevin RC; Martin L; Adams A; Macdonald C; Manning JJ; Boyd R; Cunningham M; Stevens MY; McGregor IS; Glass M; Connor M; Gerona RR, 2018, The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogues,

Conference Abstracts | 2018

Lintzeris N; Allsop D; Bhardwaj A; Mills L; Dunlop AJ; Copeland J; McGregor I; Bruno R; Gugusheff J; Phung N; Montebello M; Chan T; Kirby A; Hall M; Jefferies M; Luksza MJ; Shanahan M; Kevin R, 2018, 'FINDINGS OF A PLACEBO-CONTROLLED RANDOMISED CONTROLLED TRIAL OF NABIXIMOLS IN THE TREATMENT OF CANNABIS DEPENDENCE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S45 - S46,

Conference Papers | 2016

Banister S; Longworth M; Stuart J; Kevin R; Glass M; Gerona R; Connor M; Mcgregor I; Kassiou M, 2016, 'Evolution of synthetic cannabinoid designer drugs', in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC,

��������Ƶ

Follow

Dr Richard Kevin

Follow me

��Ƶ